IL-33 and ST2 were proposed to comprise a cardioprotective signaling system because IL-33 was found to antagonize cardiac hypertrophy as well as hypoxia-induced apoptosis in vitro and in vivo and was thereby shown to protect mice from experimental pressure overload and myocardial infarction [7], [31]. The gene discussed is IL33; the disease is myocardial infarction.